West Nile virus (WNV) is a single-stranded, positive sense RNA virus of the family Flaviviridae and is a significant pathogen of global medical importance. Flavivirus replication is known to be exclusively cytoplasmic, but we show here for the first time that access to the nucleus of the WNV strain Kunjin (WNV KUN ) RNA-dependent RNA polymerase (protein NS5) is central to WNV KUN virus production. We show that treatment of cells with the specific nuclear export inhibitor leptomycin B (LMB) results in increased NS5 nuclear accumulation in WNV KUN -infected cells and NS5-transfected cells, indicative of nucleocytoplasmic shuttling under normal conditions. We used site-directed mutagenesis to identify the nuclear localisation sequence (NLS) responsible for WNV KUN NS5 nuclear targeting, observing that mutation of this NLS resulted in exclusively cytoplasmic accumulation of NS5 even in the presence of leptomycin B.
Kochs, Khromykh, & Mackenzie, 2007; . Contrary to this, during YFV, JEV, DENV, and more recently ZIKV infection, a significant proportion of NS5 is observed within the nucleus, potentially contributing to replication and immune perturbation (Buckley, Gaidamovich, Turchinskaya, & Gould, 1992; Grant et al., 2016; Pryor et al., 2007; Uchil, Kumar, & Satchidanandam, 2006) .
The nuclear localisation of DENV NS5 during infection has been demonstrated to be a significant requisite for replication, as inhibition of nuclear import results in a severe decrease in viral titres (Wagstaff, Sivakumaran, Heaton, Harrich, & Jans, 2012) . This suggests that although viral replication has been well documented to occur within the cytoplasm, there is some functional need for NS5 to also gain access to the nucleus. Specific residues of a putative nuclear localisation sequence (NLS) within DENV NS5 have also been mutated to interrogate the nuclear trafficking functionality of NS5, identifying that import is mediated via the importin superfamily of proteins (Pryor et al., 2007) .
Importin proteins facilitate the highly regulated, essential process of nucleo-cytoplasmic translocation for efficient transcription and translation, and transport occurs via a large proteinaceous structure known as the nuclear pore complex (Davis & Blobel, 1986; Weis, 1998) . However, a clear function of DENV NS5 within the nucleus is not yet fully understood but may have roles in inhibiting the host antiviral response, in particular by modulating interleukin-8 levels (Rawlinson, Pryor, Wright, & Jans, 2009) or interferon (De Maio et al., 2016) .
Like other flaviviruses, WNV replication occurs within the cytoplasm of infected cells, (Gillespie et al., 2010; , and up to now, the cellular localisation of NS5 has previously observed to be at sites of cytoplasmic replication (Mackenzie, Kenney, & Westaway, 2007) . In this study, we have shown for the first time that WNV strain Kunjin (WNV KUN ) NS5 has the ability to access the nucleus.
With the use of small chemical inhibitors, we have been able to visualise, for the first time, an accumulation of NS5 within the nucleus and, by blocking this localisation, have observed a decrease in viral replication fitness and virus production. Through site-directed mutagenesis, we have interrogated a putative bipartite NLS found within NS5, identifying the crucial sequence required for nuclear localisation. We have combined the inhibition and mutational experiments with live cell microscopy to kinetically visualise these events in real time. Our results indicate that WNV KUN NS5 has an integral role within the nucleus and that inhibiting its entry is severely detrimental to viral replication.
| RESULTS

| WNV KUN NS5 localises to the nucleus and cytoplasm during infection
NS5 from DENV1-4 has been reported to show nucleocytoplasmic trafficking in infected cells (Tay et al., 2013) , with virus infection being reduced by inhibitors of nuclear import such as 4-HPR (Fraser et al., 2014) . Our previous observations indicated that 4-HPR also inhibited WNV replication; therefore, we examined the ability of the WNV KUN NS5 protein to traffic to the nucleus. Initially, we examined the effect of the small molecular inhibitor of nuclear export LMB on localisation of the WNV KUN proteins NS3 and NS5 during infection (Figure 1 ). In FIGURE 1 WNV KUN NS5 protein accumulates in the nucleus upon nuclear export inhibition. Vero cells were infected with WNV KUN at MOI 5 for 24 hr and were left untreated (a-c) or treated with 10-nM LMB at 2 h.p.i (d-f). Cells were subsequently fixed for IF analysis and labelled with either anti-NS3 (red; panels a and d) or anti-NS5 (green; panels b and e) antibodies. The nucleus is counterstained with DAPI (blue; panels c and f), and the merged images are provided (panels c and f). The white arrows highlight nuclear accumulation of NS5, and not NS3, in the LMB-treated cells FIGURE 2 Nuclear import inhibition restricts WNV KUN NS5 to the cytoplasm in infected cells. (a) Vero cells were left untreated or treated with nuclear transport inhibitors (LMB, or GSP) , and infected with WNV KUN at MOI 5 for 24 hr. Cells were subsequently fixed and stained for IF analysis with anti-NS5 (red; panels i, v, ix, xii, and xvii) and anti-KPNA (green; panels ii, vi, x, xiv, and xviii) antibodies. The nucleus was counterstained with DAPI (blue; panels iii, vii, xi, xv, and xix), and merged images are provided (panels iv, viii, xii, xvi, and xx). (b) Mean nuclear fluorescence was quantified using the software FIJI 2.0.0 and Fn/c determined. Ninety cells per sample were analysed over triplicate experiments. Error bars represent ±SD untreated, infected cells WNV KUN NS3 and NS5 were predominantly cytoplasmic as previously observed . NS3 displayed a primarily perinuclear staining pattern with some smaller foci also observed ( Figure 1a ). NS5 was diffusely cytoplasmic, although some faint nuclear localisation was also observed (Figure 1b) . Upon 10-nM LMB treatment, nuclear accumulation of NS5, but not NS3, was clearly evident (Figure 1d-f) . These results indicate that WNV KUN NS5, in contrast to NS3, cycles continually between nucleus and cytoplasm under normal conditions. These results also clearly demonstrate that NS3 does not translocate to the nucleus as no accumulation was observed even in the presence of the nuclear export inhibitor LMB.
To determine the mechanism of nuclear trafficking, we probed WNV KUN localisation with the additional inhibitors of nuclear import 4-HPR, shown to block DENV NS5:Importin interactions (Fraser et al., 2014) and gossypol (GSP). GSP is a small molecule nuclear import inhibitor we identified to be specific for the nuclear import protein importin (Wagstaff, Rawlinson, Hearps, & Jans, 2011; manuscript in preparation) . shown not disrupt nuclear localisation (Fraser et al., 2014 ) and the NS5 staining was similar to that of the untreated samples.
Quantification of nuclear fluorescence intensity was performed to determine the proportion of nuclear NS5 throughout treatments (Figure 2b ). Mean fluorescence intensity of the nucleus (Fn) and the cytoplasm (Fc) was performed, and ratio of nuclear to cytoplasmic intensity (Fn/c) determined. NS5 nuclear fluorescence is observed to be low during infection of untreated samples, and levels remain similar or decrease with treatment of nuclear import inhibitors. Upon treatment with LMB, an increased level of nuclear NS5 was detected.
These results would indicate that nuclear import of WNV KUN NS5 is mediated via the cellular importin protein, a process that can be prevented with available import inhibitors.
| WNV KUN NS5 protein production and viral secretion decreases when nuclear import is inhibited
To elucidate the contribution of nuclear-cytoplasmic shuttling during WNV KUN replication, we treated cells with the respective nuclear import and export inhibitors (4-HPR, 4-MPR, GSP, and LMB, respectively), and cell lysates and supernatants were collected for analyses (Figure 3 ). Vero cells were treated with the inhibitors for 2 hr and subsequently infected with WNV KUN for an additional 24 hr. Our western blot analyses revealed that pretreatment of the WNV KUN -infected cells with the nuclear import inhibitors (GSP and 4-HPR) resulted in a significant decrease in detectable NS5 when compared with the vehicle controls (ethanol and dimethylsulfoxide) and cells treated with 4-MPR and LMB (Figures 3a) . This reduction in viral protein production was also reflected in a significant reduction in the production of infectious WNV KUN particles upon pretreatment with GSP and 4-HPR (Figure 3b) . Surprisingly no significant changes in WNV KUN replication were observed during inhibition of nuclear export, indicating that NS5 must enter the nucleus for efficient replication, however does not necessarily need to leave it. Tissue culture fluid was also collected at 24 h.p.i and analysed for the production of infectious virus via plaque assay (n = 3). Titre was determined as pfu/ml. Significance was determined through Student's t test. Results represent the mean ± SD Overall, these observations further support the critical role of nuclear import of the WNV KUN NS5 for efficient virus replication. This also supports previous published reports, highlighting the role for nuclear involvement of NS5 in facilitating efficient flavivirus replication (Pryor et al., 2007) . Quantitation of the extent of nuclear localisation revealed that NS5(REK mut )-GFP was abolished in its ability to translocate to the nucleus, even in the presence of LMB (Figure 4c ).
2.3
These observations further demonstrate compelling evidence that WNV KUN NS5 is actively transported into the nucleus via the use of an active NLS located at Arg-Glu-Lys (aa 389-391).
| WNV KUN NS5 protein displays a kinetic nuclear translocation
To further analyse NS5 protein kinetics after transfection, cDNA recombinant plasmids encoding NS5-GFP and NS5(REK mut )-GFP fusion proteins FIGURE 4 Nuclear localisation of WNV KUN NS5 is dependent on a functional nuclear localisation sequence. (a) Schematic diagram of the WNV KUN NS5 protein highlighting the known enzymatic domains. The putative bipartite NLS is indicated in bold and underlined. The introduced mutations are indicated in bold and red and labelled NS5(KY mut )-GFP or NS5(REK mut )-GFP. (b) Vero cells were transfected with the recombinant cDNA expression plasmids encoding WNV KUN NS5-GFP (panels i and iv), NS5(KY mut )-GFP (panels vii and x), or NS5(REK mut )-GFP (panels xiii and xvi), untreated (panels i-iii, vii-ix, and xiii-xv) or treated with LMB (panels iv-vi, x-xii, and xvi-xviii) at 12 h.p.t and subsequently fixed for IF analysis at 24 h.p.t. The nucleus was counterstained with DAPI (panels ii, v, viii, xi, xiv, and xvii), and merged images are provided (panels iii, vi, ix, xii, xv, and xviii). (c) Mean nuclear fluorescence was quantified using the software FIJI 2.0.0 and Fn/c determined. Results represent mean ± SD of 90 cells per sample over triplicate experiments were transfected into Vero cells, treated with 10-nM LMB 12 h.p.t, then live cells were imaged for 600 min at 10-min time intervals (Figure 5a , Movies S1 to S4). We observed that the untreated NS5-GFP cellular distribution in live cells was analogous to that of the fixed samples, that is, primarily cytoplasmic with minimal nuclear signal. However, after treatment with LMB, nuclear accumulation of NS5 can be observed as early as 380 min, with a significant increase by 600. Our nuclear fluorescence quantification clearly shows accumulation of NS5-GFP in the presence of LMB but minimal accumulation for NS5(REK mut )-GFP either in the presence or in the absence of LMB (Figure 5b ). (Figure 6a ). Image analysis was also performed to quantify the rate of nuclear fluorescence recovery (Figure 6b ). This recovery suggests that total NS5 protein pool may access the nucleus and cycles between the nucleus and cytoplasm. However, we do acknowledge that these experiments utilise overproduced NS5-GFP protein examined in isolation (ie, outside of the context of infection).
| NS5 NLS mutations in the WNV KUN full length infectious clone FLSDX inhibit viral replication
To interrogate the role of the NS5 NLS during virus replication, NLS mutations were introduced into the WNV KUN (Figure 7b ), whereas no protein production was evident for FLSDX-REK mut (Figure 7b ).
These observations correlated with a steady increase in viral particle secretion in the FLSDX and FLSDX-KY mut electroporated samples, whereas no detectable virus could be observed from the FLSDX-REK mut electroporated cells (Figure 7c ). Intriguingly, we were unable to efficiently rescue virus replication via complementation of WT NS5 in a BHK replicon cell line by 72 hr (Egloff, Benarroch, Selisko, Romette, & Canard, 2002; Khromykh et al., 1998; Khromykh et al., 1999 ; Figure S1 ).
Interestingly, this difficulty in restoring NS5 function is a feature also noted for NLS mutations in DENV (Kumar et al., 2013) . It came to consideration that the inclusion of this mutation may be affecting NS5 RNA polymerase functionality. To this end, we produced two Overall, these results indicate that the import of WNV KUN NS5 protein into the nucleus is a critical requirement for virus replication.
Our observations have additionally shown that NS5 protein nuclear import is facilitated by a conserved functional NLS at amino acids 389 Arg-Glu-Lys 391 within the WNV KUN NS5 protein.
| DISCUSSION
Flavivirus replication has been extensively studied and is associated with significant reassortment of the intracellular membrane architecture within the cytoplasm (Gillespie et al., 2010; Leary & Blair, 1980; Mackenzie, 2005; Westaway, Mackenzie, & Khromykh, 2002 (Buckley et al., 1992; Edward & Takegami, 1993; Forwood et al., 1999; Mackenzie et al., 2007) . In this study, we utilised a variety of techniques, including chemical inhibitors, mutagenesis studies, and real time via live cell microscopy ( Figures 1-7) , to enable the first time visualisation of WNV KUN NS5 nuclear localisation. Additionally, we have identified a conserved NLS within NS5 (Figure 4) , and mutation of this motif within a recombinant NS5 plasmid and the WNV KUN infectious clone impaired nuclear localisation and was lethal to virus replication, respectively (Figure 7 ).
Overall, our results support and extend the crucial role the nucleus plays during flavivirus replication and indicates that nuclear import of NS5 (and perhaps other factors) is critical for efficient virus replication, although intriguingly, their export from the nucleus is not.
The most important observation from these studies is that inhibition of nuclear import, via either chemical inhibition or via mutagenesis of the NS5 NLS, severely impacted on WNV KUN 
(a) At 48 h.p.e, the electroporated cells were fixed for IF analysis and visualised with anti-NS1 antibodies and anti-IgG 488 (green; panels iv-vi). The nucleus was counterstained with DAPI (blue; panels i-iii). (b)
Western blot analysis of cell lysates collected from electroporated cells at 24, 48, and 72 h.p.e was performed. The membrane was probed with anti-NS1, anti-NS5, and anti-PDI antibodies. (c) Tissue culture fluid was collected from the electroporated cells at 24, 48, and 72 h.p.e and analysed for the virus production via plaque assay. Results reflect mean ± SD over triplicate experiments. (d) To determine the RNA-dependent RNA polymerase activity of the WNV KUN WT and REK mut proteins, a fluorescence-based assay was used as previously described (Eltahla et al., 2014) . Reactions contained 400 ng of the target protein. Enzymatic activity was determined by subtracting a blank containing heat-inactivated enzyme in this study. However, our mutagenesis studies would indicate a direct effect by NS5 alone. We believe the nuclear import of NS5 is not directly affecting WNV KUN RNA replication, as (a) dsRNA is not observed within the nucleus of infected cells and (b) NS5 within the nucleus does not need to be exported back out to enable virus replication ( Figure 3 ). This would intimate that the pool of NS5 that enters the nucleus is not required for viral replication and that NS5 associated with the RC most likely remains resident and immobile within this viral compartment. We have previously shown that many of the viral proteins are recycled during genome amplification (Westaway, Khromykh, & Mackenzie, 1999) , and earlier, seminal studies have indicated that only a very small faction of the NS5 pool is utilised during viral RNA replication (Chu & Westaway, 1987) . Thus, we would postulate that NS5 is affecting some cellular function to promote replication, potentially effects on cellular transcription.
However, we do note that we have only confirmed that the NLS 
| Plaque assay
Vero cells were seeded in DMEM complete medium in six-well plates,
followed by incubation at 37°C overnight. The virus stock was diluted 10-fold in 0.2% BSA-DMEM, used to infect previously seeded Vero 
| Transfection
Vero cells were seeded in DMEM complete onto methanol- Culture medium was collected 24 h.p.i.
| Antibodies
Mouse antiflavivirus-NS1 (clone 4G4) and mouse anti-WNV-NS5
(clone 5H1.1) monoclonal antibodies (Hall et al., 2009 , Macdonald et al., 2005 were generously provided by Roy Hall (University of Queensland). Rabbit anti-Karyopherin alpha (KPNA) antibody was purchased from BD antibodies. Mouse anti-GAPDH was purchased from cell signalling technology. Antirabbit-and antimouse-specific IgGAlexa Fluor 488, 597, and 647 were purchased from molecular probes (Invitrogen). 
| Immunofluorescence analysis
| RNA-dependent RNA polymerase activity assay
NS5 and NS5(REK mut ) constructs were created in pET24b to incorporate a hexahistidine affinity tag at the 5′ end with NEBuilder HiFi DNA assembly cloning kit (NEB). Protein expression was performed in T7
Express competent E. coli (NEB), after induction with 0.5-mM IPTG at 37°C. RdRp purification was performed by lysing (50-mM TrisHCl pH 7.5, 300-mM NaCl, 0.1% Triton™-X 100, 2-mM β-mercaptoethanol) E. coli and clearing on HiTRAP TALON crude column (GE Health care). Eluted fractions were concentrated with Amicon ultracentrifugal filter (Merck). Protein concentration was determined using a Pierce® BCA Protein Assay Kit (Pierce Biotechnology).
WNV KUN NS5 and REK mut RdRp activity was determined through fluorescence-based assay as described (Eltahla, Lackovic, Marquis, Eden, & White, 2013) .
